Generated by AI
Integra LifeSciences Holdings Corporation is a medical technology company that develops, manufactures, and markets products used in neurosurgery, regenerative medicine, and surgical reconstruction. The company’s current business is organized around two main segments, Codman Specialty Surgical and Tissue Technologies, which support procedures in neurosurgery, neurocritical care, otolaryngology, wound repair, and tissue reconstruction. Its portfolio includes surgical instruments, dural repair products, cerebrospinal fluid management devices, cranial stabilization tools, and regenerative tissue technologies designed for complex wound and reconstructive care. Integra LifeSciences Holdings Corporation serves hospitals, surgery centers, and specialist clinicians across a range of medical disciplines, making it an important supplier in the healthcare equipment market. Headquartered in Princeton, New Jersey, the company focuses on providing clinically oriented solutions for procedures that require precision, reliability, and specialized surgical support.
Website1100 Campus Road
Princeton, NJ, 08540
United States
The latest articles about IART.
Integra LifeSciences Holdings has seen a sharp reset in recent years, yet the shares have climbed back to US$14.12, which raises a clear question about what its cash flows really support today. After such a mixed share price path, investors are increasingly asking whether the current valuation is still grounded in the money the business can generate over time. Over the past 5 years the stock has fallen 79.3%. This puts the focus squarely on whether the current US$14.12 price is now aligned...
PRINCETON, N.J., Nov. 06, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that Lea Knight, chief financial officer, will present at the 2026 UBS Global Healthcare Conference on Monday, November 9, 2026, at 2:45 p.m. ET. A live webcast of the presentation will be available on the Integra LifeSciences investor relations website under EVENTS & PRESENTATIONS. About Integra LifeSciences Integra LifeScience
Summary of May 5's posts. Generated by AI.
No summary yet.
Integra LifeSciences reported third quarter 2026 sales of US$411.18 million and net income of US$14.85 million, with diluted earnings per share from continuing operations of US$0.19 compared with a diluted loss a year earlier. The company paired this return to profitability with fresh fourth quarter 2026 revenue guidance and plans to showcase key neurosurgery technologies at a major clinical meeting. Together these developments highlight both current operating traction and an effort to keep...
Summary of Oct 28's posts. Generated by AI.
Summary of May 5's posts. Generated by AI.
Investors talking about IART also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.